Get started
Telix Pharmaceutical Ltd.Telix Pharmaceutical Ltd.Telix Pharmaceutical Ltd.

Telix Pharmaceutical Ltd.

No trades
See on Supercharts
Overview
Financials News Ideas Minds Technicals Forecast

TLPPF chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪3.85 B‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
1149.71
Basic EPS (TTM)
0.01USD
Net income (FY)
‪3.55 M‬USD
Revenue (FY)
‪342.12 M‬USD
Shares float
‪253.22 M‬
Beta (1Y)
1.11

About TELIX PHARMACEUTICALS LIMITED

Sector
Health Technology
Industry
Biotechnology
CEO
Christian P. Behrenbruch
Website
telixpharma.com
Headquarters
Melbourne
Founded
2017
ISIN
AU000000TLX2
FIGI
BBG00LJTBTM9
Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of TLPPF is 11.51 USD — it has decreased by 0.35% in the past 24 hours. Watch Telix Pharmaceutical Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Telix Pharmaceutical Ltd. stocks are traded under the ticker TLPPF.
TLPPF stock has fallen by 3.11% compared to the previous week, the month change is a 9.78% rise, over the last year Telix Pharmaceutical Ltd. has showed a 64.43% increase.
We've gathered analysts' opinions on Telix Pharmaceutical Ltd. future price: according to them, TLPPF price has a max estimate of 17.30 USD and a min estimate of 9.25 USD. Watch TLPPF chart and read a more detailed Telix Pharmaceutical Ltd. stock forecast: see what analysts think of Telix Pharmaceutical Ltd. and suggest that you do with its stocks.
TLPPF reached its all-time high on May 31, 2024 with the price of 12.48 USD, and its all-time low was 0.64 USD and was reached on Mar 12, 2020. View more price dynamics on TLPPF chart.
See other stocks reaching their highest and lowest prices.
TLPPF stock is 5.62% volatile and has beta coefficient of 1.11. Track Telix Pharmaceutical Ltd. stock price on the chart and check out the list of the most volatile stocks — is Telix Pharmaceutical Ltd. there?
Today Telix Pharmaceutical Ltd. has the market capitalization of ‪3.68 B‬, it has decreased by 5.88% over the last week.
Yes, you can track Telix Pharmaceutical Ltd. financials in yearly and quarterly reports right on TradingView.
Telix Pharmaceutical Ltd. is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
Telix Pharmaceutical Ltd. revenue for the last quarter amounts to ‪114.12 M‬ USD, despite the estimated figure of ‪114.12 M‬ USD. In the next quarter, revenue is expected to reach ‪98.03 M‬ USD.
No, TLPPF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Telix Pharmaceutical Ltd. EBITDA is ‪39.78 M‬ USD, and current EBITDA margin is 11.63%. See more stats in Telix Pharmaceutical Ltd. financial statements.
Like other stocks, TLPPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Telix Pharmaceutical Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Telix Pharmaceutical Ltd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Telix Pharmaceutical Ltd. stock shows the buy signal. See more of Telix Pharmaceutical Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.